Asia is a modern hybrid-sativa developed from a genetic lineage encompassing mostly sativa, the high-CBD Doctor Seedsman 30:1, and the Greek Kalamata cultivar. The specific breeding history and origin of this strain remain undocumented, leaving its precise development timeline and creator unknown to the public record. It is categorized as a modern hybrid rather than a landrace variety, reflecting its place in contemporary cultivation programs that balance traditional sativa characteristics with refined genetic traits.

The chemical profile of Asia is defined by a complex range of terpenes, led by pinene and myrcene, followed by ocimene, limonene, caryophyllene, beta-pinene, linalool, humulene, guaiol, bisabolol, and nerolidol. This documented terpene composition results in a distinct aromatic experience that blends pine-forward notes with earthy, herbal, and citrus undertones. As a THC-dominant cultivar, the strain produces reliable psychoactive effects for those seeking an approachable but potent profile.

Users typically report feeling creative, uplifted, and happy after consumption, making it a suitable choice for social engagements, tasks requiring focus, or creative endeavors. Cultivators looking to produce this strain should expect a moderate level of difficulty, with a flowering period lasting 66 days. Asia performs well in both indoor and outdoor environments and is known for delivering a high yield. There are currently no notable offspring recorded for this strain in the broader genetic landscape.